Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
8,869.00
9,151.00
8,171.00
7,081.00
6,559.00
6,314.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
8,869.00
9,151.00
8,171.00
7,081.00
6,559.00
6,314.00
Expenditure (Ex Depriciation)
Stock Adjustments
-187.00
-241.00
-198.00
68.00
55.00
-52.00
Raw Materials Consumed
3,426.00
3,473.00
3,152.00
2,634.00
2,396.00
2,111.00
Power & Fuel Cost
260.00
267.00
241.00
207.00
163.00
136.00
Employee Cost
2,415.00
2,307.00
2,029.00
1,896.00
1,588.00
1,467.00
Operating Expenses
630.00
607.00
571.00
531.00
460.00
445.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
431.00
392.00
352.00
369.00
317.00
250.00
Cost of Software developments
56.00
42.00
31.00
30.00
0.00
0.00
Miscellaneous Expenses
224.00
187.00
152.00
166.00
71.00
68.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
7,947.00
7,706.00
6,974.00
6,453.00
5,609.00
4,886.00
Operating Profit (PBDIT) excl Other Income
921.00
1,444.00
1,196.00
628.00
949.00
1,427.00
Other Income
213.00
134.00
175.00
225.00
275.00
164.00
Operating Profit (PBDIT)
1,134.00
1,579.00
1,371.00
853.00
1,225.00
1,592.00
Interest
340.00
421.00
448.00
344.00
198.00
163.00
Profit before Depriciation and Tax
794.00
1,158.00
923.00
509.00
1,027.00
1,428.00
Depreciation
831.00
816.00
740.00
676.00
586.00
545.00
Profit Before Taxation & Exceptional Items
-37.00
341.00
182.00
-167.00
441.00
883.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
-176.00
414.00
179.00
-120.00
484.00
949.00
Provision for Tax
149.00
323.00
161.00
66.00
109.00
114.00
Profit After Tax
-383.00
18.00
-41.00
-240.00
316.00
787.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
1,049.00
970.00
956.00
1,158.00
832.00
835.00
Profit Available for appropriations
723.00
1,061.00
974.00
972.00
1,208.00
1,670.00
Appropriations
723.00
1,061.00
974.00
972.00
1,208.00
1,670.00
Equity Dividend (%)
0.00%
1.40%
1.10%
0.00%
0.00%
0.00%
Earnings Per Share
-2.46
0.69
0.14
-1.54
3.19
13.30
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is -3.08% vs 11.99% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is -36.21% vs 20.78% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -19.16% vs -6.00% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is -2,205.16% vs 143.68% in Mar 2025
Compare Profit and Loss Results of Piramal Pharma
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
8,869.00
1,694.00
7,175.00
423.55%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
8,869.00
1,694.00
7,175.00
423.55%
Expenditure (Ex Depriciation)
Stock Adjustments
-187.00
4.00
-191.00
-4,775.00%
Raw Materials Consumed
3,426.00
460.00
2,966.00
644.78%
Power & Fuel Cost
260.00
48.00
212.00
441.67%
Employee Cost
2,415.00
549.00
1,866.00
339.89%
Operating Expenses
630.00
94.00
536.00
570.21%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
431.00
11.00
420.00
3,818.18%
Cost of Software developments
56.00
0.00
56.00
0%
Miscellaneous Expenses
224.00
35.00
189.00
540.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
7,947.00
1,286.00
6,661.00
517.96%
Operating Profit (PBDIT) excl Other Income
921.00
407.00
514.00
126.29%
Other Income
213.00
36.00
177.00
491.67%
Operating Profit (PBDIT)
1,134.00
444.00
690.00
155.41%
Interest
340.00
78.00
262.00
335.90%
Profit before Depriciation and Tax
794.00
366.00
428.00
116.94%
Depreciation
831.00
138.00
693.00
502.17%
Profit Before Taxation & Exceptional Items
-37.00
227.00
-264.00
-116.30%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-176.00
227.00
-403.00
-177.53%
Provision for Tax
149.00
57.00
92.00
161.40%
Profit After Tax
-383.00
170.00
-553.00
-325.29%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1,049.00
553.00
496.00
89.69%
Profit Available for appropriations
723.00
723.00
0.00
0.00%
Appropriations
723.00
723.00
0.00
0.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-2.46
8.83
-11.29
-127.86%
Profit And Loss - Net Sales
Net Sales 8,869.08 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -3.08% vs 11.99% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 921.62 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -36.21% vs 20.78% in Mar 2025
Profit And Loss - Interest
Interest 340.80 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -19.16% vs -6.00% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax -383.14 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -2,205.16% vs 143.68% in Mar 2025






